THESAURA WHEATON: Open Payments
NPI 1144721358 · PALMDALE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,349 in 56 payments from 20 companies in 2025. Trend: 2023 $1,459 · 2024 $1,235 · 2025 $1,349
Food & beverage: $1,349
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $199 |
| Lilly USA, LLC | 8 | $190 |
| AstraZeneca Pharmaceuticals LP | 10 | $170 |
| Merck Sharp & Dohme LLC | 6 | $135 |
| Novo Nordisk Inc | 4 | $81 |
| Amgen Inc. | 4 | $78 |
| SANOFI PASTEUR INC. | 3 | $73 |
| Verity Pharmaceuticals Inc. | 2 | $62 |
| Dexcom, Inc. | 2 | $60 |
| Astellas Pharma US Inc | 2 | $55 |
Products named: MOUNJARO, BOTOX, VERQUVO, AIRSUPRA, Tlando, Dexcom G6 Transmitter, Veozah, REXULTI.
Industry payments across CA — which companies pay providers there.
